Evidence map›Paper›PMID 25829393›Full record

ArticlePhysiological genomics2015

Evidence for a link between gut microbiota and hypertension in the Dahl rat.

Blair Mell, Venkatakrishna R Jala, Anna V Mathew, Jaeman Byun, Harshal Waghulde, Youjie Zhang, Bodduluri Haribabu, Matam Vijay-Kumar, Subramaniam Pennathur, Bina Joe

Open access · greenAbstract read
In one paragraph

Article in Physiological genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 252 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
252citing papers in PubMed, 2 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

252 citing papers in PubMed, 2 syntheses or guidelines pooled it, 409 citations in OpenAlex.

  1. Targeting Gut Microbiota to Treat Hypertension: A Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. The Microbiota as a Potential Cause of Disease.Diseases (Basel, Switzerland) · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Potential protective effects ofFrontiers in pharmacology · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Article

192 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Blair MellCenter for Hypertension and Personalized Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio;
Venkatakrishna R JalaJames Graham Brown Cancer Center, Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky;
Anna V MathewDivision of Nephrology, Department of Internal Medicine, University of Michigan, Medical School, Ann Arbor, Michigan; and.
Jaeman ByunDivision of Nephrology, Department of Internal Medicine, University of Michigan, Medical School, Ann Arbor, Michigan; and.
Harshal WaghuldeCenter for Hypertension and Personalized Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio;
Youjie ZhangCenter for Hypertension and Personalized Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio;
Bodduluri HaribabuJames Graham Brown Cancer Center, Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky;
Matam Vijay-KumarDepartment of Nutritional Sciences and Medicine, The Pennsylvania State University, University Park, Pennsylvania.
Subramaniam PennathurDivision of Nephrology, Department of Internal Medicine, University of Michigan, Medical School, Ann Arbor, Michigan; and.
Bina JoeCenter for Hypertension and Personalized Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio; bina.joe@utoledo.edu.
University of Toledo · USUniversity of Michigan–Ann Arbor · USUniversity of Louisville · USPennsylvania State University · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
University of Michigan O'Brien Kidney Translational Core CenterP30DK081943 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROSIUS, FRANK C · 2008 to 2022
$12.9M
Statistics and Bioinformatics Core - WangU24DK097153 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BURANT, CHARLES F · 2012 to 2017
$10.1M
Genetics of HypertensionR01HL020176 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI JOE, BINA · 1985 to 2017
$8.1M
Innovative Models for Mechanistic Studies of Novel Hypertension GenesR01HL112641 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI JOE, BINA · 2012 to 2016
$3.3M
Genetics of HypertensionR01HL076709 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI JOE, BINA · 2008 to 2011
$1.6M
BIOCHEMISTRY AND GENETICS OF HYPERTENSIONR37HL020176 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI RAPP, JOHN P · 1993 to 2002
$1.6M
NHLBI NIH HHS HL-020176NHLBI NIH HHS HL-076709NHLBI NIH HHS HL-112641NHLBI NIH HHS R01 HL020176NHLBI NIH HHS R01 HL076709NHLBI NIH HHS R01 HL112641NHLBI NIH HHS R37 HL020176NIDDK NIH HHS DK-08194NIDDK NIH HHS DK-097153NIDDK NIH HHS DK-89503NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK081943NIDDK NIH HHS P30 DK089503NIDDK NIH HHS U24 DK097153
6 · The paper itself

Abstract

The gut microbiota plays a critical role in maintaining physiological homeostasis. This study was designed to evaluate whether gut microbial composition affects hypertension. 16S rRNA genes obtained from cecal samples of Dahl salt-sensitive (S) and Dahl salt-resistant (R) rats were sequenced. Bacteria of the phylum Bacteroidetes were higher in the S rats compared with the R rats. Furthermore, the family S24-7 of the phylum Bacteroidetes and the family Veillonellaceae of the phylum Firmicutes were higher in the S rats compared with the R rats. Analyses of the various phylogenetic groups of cecal microbiota revealed significant differences between S and R rats. Both strains were maintained on a high-salt diet, administered antibiotics for ablation of microbiota, transplanted with S or R rat cecal contents, and monitored for blood pressure (BP). Systolic BP of the R rats remained unaltered irrespective of S or R rat cecal transplantation. Surprisingly, compared with the S rats given S rat cecal content, systolic BP of the S rats given a single bolus of cecal content from R rats was consistently and significantly elevated during the rest of their life, and they had a shorter lifespan. A lower level of fecal bacteria of the family Veillonellaceae and increased plasma acetate and heptanoate were features associated with the increased BP observed in the S rats given R rat microbiota compared with the S rats given S rat microbiota. These data demonstrate a link between microbial content and BP regulation and, because the S and R rats differ in their genomic composition, provide the necessary basis to further examine the relationship between the host genome and microbiome in the context of BP regulation in the Dahl rats.

Indexed as

Gastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsBlood PressureCecumFatty AcidsGenetic VariationGenomeHypertensionKaplan-Meier EstimateLongevityMetabolomicsRats, Inbred DahlSodiumSystoleAnti-Bacterial AgentsFatty AcidsSodiumgutmetabolicmetabolomicsmicrobialSCFA

Identifiers

PMID25829393
PMCPMC4451389
OpenAlexW2024324459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.